Stock Taper
EXCHANGE TRADED FUND

TDNA

T. Rowe Price Biotech ETF
$24.20 ▲ 2.63%
+$0.62 TODAY

FUND FACTS

Manager T. Rowe
Assets $9.6M
Expense ratio 0.55%
Inception Sep 16, 2026
Asset class Equity
Holdings 86
Volume 2.41K
Avg volume 2.01K

ABOUT THIS FUND

T. Rowe Price Biotech ETF is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing primarily in biotechnology and life sciences companies. The fund focuses on companies developing innovative therapies, medicines, and technologies across areas such as biotechnology, pharmaceuticals, and medical research. T. Rowe Price lists the fund under the ticker TDNA.

PRICE

$24.20 ▲ UP 2.63% (+$0.62)
$23.85$24.00$24.159:32 AM9:58 AM10:24 AM10:51 AM11:17 AM11:43 AM12:09 PM24.20

HOLDINGS

TOP 20 OF 86 · 46.32% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 ARGX argenx SE 5.49% 567 $527.6K
02 KYMR Kymera Therapeutics, Inc. 4.00% 3.63K $384.6K
03 KOD Kodiak Sciences Inc. 2.73% 2.84K $261.88K
04 INSM Insmed Incorporated 2.50% 2.28K $240.03K
05 NTRA Natera, Inc. 2.44% 586 $234.78K
06 RVMD Revolution Medicines, Inc. 2.42% 1.16K $232.05K
08 PCVX Vaxcyte, Inc. 2.28% 3.28K $218.91K
10 DNTH Dianthus Therapeutics, Inc. 1.94% 2.18K $186.34K
11 MRNA Moderna, Inc. 1.94% 992 $185.96K
12 BBIO BridgeBio Pharma, Inc. 1.92% 2.76K $184.81K
15 RYTM Rhythm Pharmaceuticals, Inc. 1.81% 1.91K $173.46K
16 CYTK Cytokinetics, Incorporated 1.78% 2.79K $171.1K
18 SYRE Spyre Therapeutics, Inc. 1.68% 2.02K $161.42K
19 ALKS Alkermes plc 1.66% 3.82K $159.19K

SECTOR HOLDINGS

TECHNOLOGY IS 1.00% OF THE FUND

BY REGION

UNITED STATES IS 88.42% OF THE FUND
United States 88.42%
Netherlands 5.49%
Ireland 1.66%
United Kingdom 1.41%
— Other 1.31%
Denmark 0.75%
Canada 0.64%
France 0.30%